ITCI
Intra-Cellular Therapies Inc
Price:  
71.49 
USD
Volume:  
728,485.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI Probability of Bankruptcy

The Probability of Bankruptcy of Intra-Cellular Therapies Inc (ITCI) is 30.15% . This number represents the probability that ITCI will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ITCI's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ITCI - ESG ratings

ESG ratings are directly linked to the cost of capital and ITCI's ability to raise funding, both of which can significantly affect the probability of Intra-Cellular Therapies Inc going bankrupt.

ESG Score 47.70
Environment Score 48.44
Social Score 70.83
Governance Score 23.82
Returns
Historical Returns (5 day) -1.11%
Historical Returns (MTD) 5.63%
Historical Returns (YTD) -0.68%
Historical Returns (13 week) 19.71%
Historical Returns (26 week) 27.95%
Historical Returns (52 week) 45.07%
Efficiency
Asset Turnover 0.64
Receiveable Turnover 4.91
Gross Margin 91.90%
Operating Margin -25.81%
Pretax Margin -21.30%
Net Margin -21.63%
Return on Asset (ROA) -19.40
Return on Equity (ROE) -23.04
Return on Investments (ROI) -23.04
Price Metrics
Market Cap (M) 6,920.95
Enterprise Value (M)
52 Week High 76.03
52 Week Low 42.01
Beta 1.33
Average Volume (10 day) 0.32
Average Volume (3 month) 0.76
Price / Earnings (P/E)
Price / Sales (P/S) 14.49
Earnings
EPS -1.46
Revenue CAGR (5 year)
Risk
Current Ratio 5.41
Quick Ratio 4.97